Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2016-02-01 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
金融服务协议
Regulatory Filings Classification · 95% confidence The document is a detailed financial services agreement between two companies, outlining terms of cooperation, services provided, commitments, confidentiality, dispute resolution, and other contractual clauses. It is a contract or agreement rather than a financial report, regulatory filing, or announcement. There is no indication of financial statements, audit results, management changes, earnings data, or regulatory disclosures. It does not fit into any of the specific financial report or announcement categories. Therefore, the best fitting category is Regulatory Filings (RNS) as a fallback for miscellaneous filings that do not fit other categories.
2016-02-01 Chinese
独立董事对公司第七届董事会临时会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on various company matters including financial service agreements, risk assessment reports, risk disposal plans, board member nominations, external guarantees, adjustments to non-public stock issuance plans, and related financial impact analyses. It references compliance with laws, regulations, and governance rules, and provides independent opinions on these corporate governance and financial matters. The document is not a full annual or interim financial report, nor is it a simple announcement or certification. It is a detailed governance-related opinion document issued by independent directors, which fits best under Board/Management Information (MANG) as it relates to board decisions, director nominations, and governance opinions. The document length is under 5,000 characters, but it contains substantive independent opinions rather than just an announcement of a report publication, so it is not RPA or RNS. Therefore, the classification is MANG with high confidence.
2016-02-01 Chinese
独立董事对公司第七届董事会临时会议相关议案的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding several proposals to be discussed at a company's board meeting, including financial service agreements and adjustments to a non-public stock issuance plan. It references compliance with company law, securities law, and governance codes, and provides pre-approval opinions on these proposals. The content focuses on board/management level decisions and approvals rather than financial results, audit findings, or shareholder voting outcomes. The document length is short (952 characters) and it is not a report or announcement of a report publication. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions at the board or senior management level.
2016-02-01 Chinese
控股股东、实际控制人、董事、高级管理人员关于非公开发行股票摊薄即期回报采取填补措施的承诺
Regulatory Filings Classification · 95% confidence The document is an announcement from the company and its controlling shareholders and senior management regarding commitments related to measures to compensate for dilution of immediate returns caused by a non-public stock issuance. It references regulatory guidelines and contains commitments from directors and controlling shareholders. The document is short (905 characters) and is a formal announcement of commitments rather than a financial report or detailed filing. It does not contain financial statements or detailed financial data. It is not a report itself but an announcement related to corporate governance and shareholder interests. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2016-02-01 Chinese
关于非公开发行股票认购对象穿透后涉及认购主体数量的说明公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 紫光古汉集团股份有限公司 regarding the details of the non-public issuance of shares, specifically about the number of subscription entities after a transparency check. It includes details about the investors and the number of underlying entities involved. The document is relatively short (2200 characters) and focuses on the explanation of the subscription subjects for a private placement of shares. It does not contain financial statements or detailed financial performance data. It is an update related to capital raising activities, specifically a non-public share issuance. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2016-02-01 Chinese
关于公司全资子公司对外担保的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 紫光古汉集团股份有限公司 regarding a guarantee provided by its wholly-owned subsidiary for a credit facility extended by a bank to a third party. It details the terms of the guarantee, the parties involved, financial background of the guaranteed party, and the board's opinion on the guarantee. The document is an announcement of a corporate action related to external guarantees and does not contain financial statements, audit opinions, or detailed financial results. It is not a full annual or interim report, nor is it a call transcript or management discussion. The document is a regulatory announcement about a guarantee arrangement, fitting best into the category of Regulatory Filings (RNS) as it does not fit other more specific categories and is a formal disclosure to the market.
2016-02-01 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.